Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)»Myeloid leukemia (C92)
C92
Myeloid leukemia
Sub-codes (10)
- C92.0 Acute myeloblastic leukemia
1 indication for 1048 drugs
- C92.1 Chronic myeloid leukemia, BCR/ABL-positive
- C92.2 Atypical chronic myeloid leukemia, BCR/ABL-negative
2 indications for 770 drugs
- C92.3 Myeloid sarcoma
1 indication for 40 drugs
- C92.4 Acute promyelocytic leukemia
1 indication for 35 drugs
- C92.5 Acute myelomonocytic leukemia
1 indication for 70 drugs
- C92.6 Acute myeloid leukemia with 11q23-abnormality
- C92.9 Myeloid leukemia, unspecified
- C92.A Acute myeloid leukemia with multilineage dysplasia
- C92.Z Other myeloid leukemia
Related indications (MeSH) (1)
Leukemia, Myeloid101 drugs (65 approved, 36 experimental)
Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.